Herbalife is reporting Q2 EPS of $1.55 ex-items on revenue of $1.31 billion, with CNBC's Bertha Coombs and Kelly Evans.
Herb Greenberg, CNBC contributor, provides a reality check on whether or not billionaire investor Bill Ackman actually made his case against Herbalife.
Herbalife has gained 25 percent today after hedge fund manager Bill Ackman gave a presentation on the company. Jared Bernstein, weighs in on the press the company is getting.
CNBC's Scott Wapner reports Herbalife has responded to investor Bill Ackman by saying Ackman has over-promised and undelivered and his claims are completely false and fabricated.
CNBC contributor Herb Greenberg discusses investor Bill Ackman's presentation on Herbalife and whether he overhyped the marketing company's downfall.
Hedge fund manager Bill Ackman is laying out his case against Herbalife. CNBC's Herb Greenberg, Kate Kelly and Scott Wapner, provide perspective.
Robert Chapman, Chapman Capital, says he is adding aggressively to Herbalife despite Bill Ackman's criticism of the company. Also Chapman explains why he thinks the stock could hit $150 per share within a year.
CNBC's Kate Kelly reports on Bill Ackman's presentation on Herbalife. Perhaps he over-hyped this, says Kelly. And Herb Greenberg, Herb Greenberg's Reality Check editor, shares his thoughts on what's likely driving Herbalife's trading action.
CNBC's Kate Kelly reports investor Bill Ackman spent $50 million on an undercover investigation into Herbalife. Ackman says Herbalife has "phantom or fictitious customers."